Entyvio 300 MG vials
Ended Awarded
- Contract number
- SPE2DB25FWUVH
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $44,504
Award facts
- Contract value 100% obligated
- $44,504.37 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a firm fixed-price delivery order valued at $44,504.37 by the Defense Logistics Agency (DLA) on July 23, 2025. The delivery order, which is expected to be completed by August 13, 2025, covers the supply of Entyvio 300 mg vials—a biologic medication used to treat inflammatory bowel diseases. This award was issued without a set-aside designation, demonstrating the company's competitive positioning within the federal pharmaceutical procurement landscape. The place of performance is located at the company's headquarters in Park Ridge, Illinois.
This delivery order is issued under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with the DLA under the SPE2DB program, valued at $499.999 billion and valid through November 2026. This IDC enables the agency to procure a comprehensive range of pharmaceutical products supporting the medical supply needs of military healthcare facilities worldwide. DMS Pharmaceutical Group's contract portfolio reflects its established role as a critical supplier within the Department of Defense pharmaceutical supply chain, providing distribution of both branded and generic prescription drugs, biologics, and medical consumables to federal healthcare systems nationwide.
Quick answers
Who was awarded contract SPE2DB25FWUVH?
SPE2DB25FWUVH was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on July 23, 2025.
How much is contract SPE2DB25FWUVH worth?
The government has obligated $44,504 on SPE2DB25FWUVH.
Is contract SPE2DB25FWUVH an order under another contract?
Yes. SPE2DB25FWUVH is a delivery order under SPE2DB25D9312, an indefinite delivery contract.
Was contract SPE2DB25FWUVH competed?
The extent of competition for SPE2DB25FWUVH was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award